In this abridgement, Penn radiologist Jill Langer, MD, offers a consideration of molecular testing for thyroid biopsy. Her discussion focuses upon the use and characteristics of thyroid fine needle aspiration (FNA) cytology as a measure of cancer risk, as well as standards of care for indeterminate thyroid cytology and the predictive value of mutation panel, oncogene panel and GEC evaluation for thyroid cancers.

This video is an abridgement of The Use of Molecular Testing in Thyroid Biopsy, a Health e Galaxy CME program available for download or DVD purchase at www.heboards.com.